以下是在标准教科书中找不到的，本书内容的参考资料来源。

PART 1

Bandani, A. R.: Effect of Plant a-Amylase Inhibitors on Sunn Pest, Eurygaster Integriceps Puton (Hemiptera: Scutelleridae), Alpha-Amylase Activity. In: Commun Agric Appl Biol Sci. 2005; 70 (4): S. 869–873.

Baugh, R. F. et al.: Clinical Practice Guideline: Tonsillectomy in Children. In: Otolaryngol Head Neck Surg. 2011 January; 144 (Suppl. 1): S. 1–30.

Bengmark, S.: Integrative Medicine and Human Health – The Role of Pre-, Pro- and Synbiotics. In: Clin Transl Med. 2012 May 28; 1 (1):S. 6.

Bernardo, D. et al.: Is Gliadin Really Safe for Non-Coeliac Individuals？Production of Interleukin 15 in Biopsy Culture from Non-Coeliac Individuals Challenged with Gliadin Peptides. In: Gut. 2007 June; 56 (6): S. 889 f.

Bodinier, M. et al.: Intestinal Translocation Capabilities of Wheat Allergens Using the Caco-2 Cell Line. In: J Agric Food Chem. 2007 May 30; 55 (11): S. 4576–4583.

Bollinger, R. et al.: Biofilms in the Large Bowel Suggest an Apparent Function of the Human Vermiform Appendix. In: J Theor Biol. 2007 December 21; 249 (4): S. 826–831.

Catassi, C. et al.: Non-Celiac Gluten Sensitivity: The New Frontier of Gluten Related Disorders. In: Nutrients. 2013 September 26; 5 (10):S. 3839–3853.

Kim, B. H.; Gadd, G. M.: Bacterial Physiology and Metabolism. Cambridge:Cambridge University Press, 2008.

Klauser, A. G. et al.: Behavioral Modification of Colonic Function. Can Constipation Be Learned？. In: Dig Dis Sci. 1990 October; 35 (10): S. 1271–1275.

Lammers, K. M. et al.: Gliadin Induces an Increase in Intestinal Permeability and Zonulin Release by Binding to the Chemokine Receptor CXCR3. In: Gastroenterology. 2008 July; 135 (1): S. 194–204.

Ledochowski, M. et al.: Fructose- and Sorbitol-Reduced Diet Improves Mood and Gastrointestinal Disturbances in Fructose Malabsorbers. In: Scand J Gastroenterol. 2000 October; 35 (10): S. 1048–1052.

Lewis, S. J.; Heaton, K. W.: Stool Form Scale as a Useful Guide to Intestinal Transit Time. In: Scand J Gastroenterol. 1997 September;32 (9): S. 920–924.

Martín-Peláez, S. et al.: Health Effects of Olive Oil Polyphenols: Recent Advances and Possibilities for the Use of Health Claims. In: Mol.Nutr. Food Res. 2013; 57 (5): S. 760–771.

Paul, S.: Palopower – Das Wissen der Evolution nutzen für Ernhrung,Gesundheit und Genuss. München: C. H. Beck-Verlag, 2013 (2. Auflage).

Sikirov, D.: Etiology and Pathogenesis of Diverticulosis Coli: A New Approach. In: Med Hypotheses. 1988 May; 26 (1): S. 17–20.

Sikirov, D.: Comparison of Straining During Defecation in Three Positions:Results and Implications for Human Health. In: Dig Dis Sci.2003 July; 48(7): S. 1201–1205.

Thorleifsdottir, R. H. et al.: Improvement of Psoriasis after Tonsillectomy Is Associated with a Decrease in the Frequency of Circulating T Cells That Recognize Streptococcal Determinants and Homologous Skin Determinants. In: J Immunol. 2012; 188 (10): S. 5160–5165.

Varea, V. et al.: Malabsorption of Carbohydrates and Depression in Children and Adolescents. In: J Pediatr Gastroenterol Nutr. 2005 May; 40 (5): S. 561–565.

Wisner, A. et al.: Human Opiorphin, a Natural Antinociceptive Modulator of Opioid-Dependent Pathways. In: Proc Natl Acad Sci USA.2006 November 21; 103(47): S. 17 979–17 984.

PART 2

Agiulera, M. et al.: Stress and Antibiotics Alter Luminal and Walladhered Microbiota and Enhance the Local Expression of Visceral Sensory-Related Systems in Mice. In: Neurogastroenterol Motil.2013 August; 25 (8): S. e515–e529.

Bercik, P. et al.: The Intestinal Microbiota Affect Central Levels of BrainDerived Neurotropic Factor and Behavior in Mice. In: Gastroenterology.2011 August; 141 (2): S. 599–609.

Bravo, J. A. et al.: Ingestion of Lactobacillus Strain Regulates Emotional Behavior and Central GABA Receptor Expression in a Mouse via the Vagus Nerve. In: Proc Natl Acad Sci USA. 2011 September 20; 108 (38): S. 16 050–16 055.

Bubenzer, R. H.; Kaden, M.: auf www.sodbrennen-welt.de, (abgerufen im Oktober 2013).

Castren, E.: Neuronal Network Plasticity and Recovery from Depression. In: JAMA Psychiatry. 2013; 70 (9): S. 983–989.

Craig, A. D.: How Do You Feel – Now？ The Anterior Insula and Human Awareness. In: Nat Rev Neurosci. 2009 January; 10 (1): S. 59–70.

Enck, P. et al.: Therapy Options in Irritable Bowel Syndrome. In: Eur J Gastroenterol Hepatol. 2010 December; 22 (12): S. 1402–1411.

Furness, J. B. et al.: The Intestine as a Sensory Organ: Neural, Endocrine,and Immune Responses. In: Am J Physiol Gastrointest Liver Physiol.1999; 277 (5): S. G922–G928.

Huerta-Franco, M. R. et al.: Effect of Psychological Stress on Gastric Motility Assessed by Electrical Bio-Impedance. In: World J Gastroenterol.2012 September 28; 18 (36): S. 5027–5033.

Kell, C. A. et al.: The Sensory Cortical Representation of the Human Penis:Revisiting Somatotopy in the Male Homunculus. In: J Neurosci.2005 June 22; 25 (25): S. 5984–5987.

Keller, J. et al.: S3-Leitlinie der Deutschen Gesellschaft für Verdauungsund Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilitt (DGNM) zu Definition, Pathophysiologie, Diagnostik und Therapie intestinaler Motilittsstorungen. In: Z Gastroenterol. 2011; 49: S. 374–390.

Keywood, C. et al.: A Proof of Concept Study Evaluating the Effect of ADX10059, a Metabotropic Glutamate Receptor-5 Negative Allosteric Modulator, on Acid Exposure and Symptoms in Gastro-Oesophageal Reflux Disease. In: Gut. 2009 September; 58 (9): S. 1192–1199.

Krammer, H. et al.: Tabuthema Obstipation: Welche Rolle spielen Lebensgewohnheiten, Ernhrung, Pr- und Probiotika sowie Laxanzien？. In: Aktuelle Ernhrungsmedizin. 2009; 34 (1): S. 38–46.

Layer, P. et al.: S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie,Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilitt (DGNM). In: Z Gastroenterol. 2011; 49: S. 237–293.

Ma, X. et al.: Lactobacillus Reuteri Ingestion Prevents Hyperexcitability of Colonic DRG Neurons Induced by Noxious Stimuli. In: Am J Physiol Gastrointest Liver Physiol. 2009 April; 296 (4): S. G868–G875.

Mayer, E. A.: Gut Feelings: The Emerging Biology of Gut-Brain Communication. In: Nat Rev Neurosci. 2011 July 13; 12 (8): S. 453–466.

Mayer, E. A. et al.: Brain Imaging Approaches to the Study of Functional GI Disorders: A Rome Working Team Report. In: Neurogastroenterol Motil. 2009 June; 21 (6): S. 579–596.

Moser, G. (Hrsg.): Psychosomatik in der Gastroenterologie und Hepatologie. Wien; New York: Springer, 2007.

Naliboff, B. D. et al.: Evidence for Two Distinct Perceptual Alterations in Irritable Bowel Syndrome. In: Gut. 1997 October; 41 (4): S. 505–512.

Palatty, P. L. et al.: Ginger in the Prevention of Nausea and Vomiting: A Review. In: Crit Rev Food Sci Nutr. 2013; 53 (7): S. 659–669.

Reveiller, M. et al.: Bile Exposure Inhibits Expression of Squamous Differentiation Genes in Human Esophageal Epithelial Cells. In: Ann Surg. 2012 June; 255 (6): S. 1113–1120.

Revenstorf, D.: Expertise zur wissenschaftlichen Evidenz der Hypnotherapie. Tübingen, 2003; unter http://www.meg-tuebingen. de/downloads/Expertise.pdf(abgerufen im Oktober 2013).

Simons, C. C. et al.: Bowel Movement and Constipation Frequencies and the Risk of Colorectal Cancer Among Men in the Netherlands Cohort Study on Diet and Cancer. In: Am J Epidemiol. 2010 December 15; 172 (12): S. 1404–1414.

Streitberger, K. et al.: Acupuncture Compared to Placebo-Acupuncture for Postoperative Nausea and Vomiting Prophylaxis: A Randomised Placebo-Controlled Patient and Observer Blind Trial. In: Anaesthesia.2004 Februar; 59 (2): S. 142–149.

Tillisch, K. et al.: Consumption of Fermented Milk Product with Probiotic Modulates Brain Activity. In: Gastroenterology. 2013 June;144 (7): S. 1394–1401.

PART 3

Aggarwal, J. et al.: Probiotics and their Effects on Metabolic Diseases: An Update. In: J Clin Diagn Res. 2013 January; 7 (1): S. 173–177.

Arnold, I. C. et al.: Helicobacter Pylori Infection Prevents Allergic Asthma in Mouse Models through the Induction of Regulatory T Cells.In: J Clin Invest. 2011 August; 121 (8): S. 3088–3093.

Arumugam, M. et al.: Enterotypes of the Human Gut Microbiome. In:Nature. 2011 May 12; 474 (7353); 1: S. 174–180.

Bckhed, F.: Addressing the Gut Microbiome and Implications for Obesity. In: International Dairy Journal. 2010; 20 (4): S. 259–261.

Balakrishnan, M.; Floch, M. H.: Prebiotics, Probiotics and Digestive Health. In: Curr Opin Clin Nutr Metab Care. 2012 November; 15 (6):S. 580–585.

Barros, F. C.: Cesarean Section and Risk of Obesity in Childhood, Adolescence, and Early Adulthood: Evidence from 3 Brazilian Birth Cohorts. In: Am J Clin Nutr. 2012; 95 (2): S. 465–70.

Bartolomeo, F. Di.: Prebiotics to Fight Diseases: Reality or Fiction？. In: Phytother Res. 2013 October; 27 (10): S. 1457–1473.

Bischoff, S. C.; Kochling, K.: Pro- und Prbiotika. In: Zeitschrift für Stoffwechselforschung, klinische Ernhrung und Ditik. 2012; 37: S. 287–304.

Borody, T. J. et al.: Fecal Microbiota Transplantation: Indications, Methods, Evidence, and Future Directions. In: Curr Gastroenterol Rep. 2013; 15 (8): S. 337.

Brunig, J.: Verbrauchertipps zu Lebensmittelhygiene, Reinigung und Desinfektion. Berlin: Bundesinstitut für Risikobewertung, 2005.

Brede, C.: Das Instrument der Sauberkeit. Die Entwicklung der Massenproduktion von Feinseifen in Deutschland 1850 bis 2000. Münster et al.: Waxmann, 2005.

Bundesregierung: Antwort der Bundesregierung auf die Kleine Anfrage der Abgeordneten Friedrich Ostendorff, Brbel Hohn, Nicole Maisch, weiterer Abgeordneter und der Fraktion BUNDNIS 90/DIE GRUNEN – Drucksache 17/10017. Daten zur Antibiotikavergabe in Nutztierhaltungen und zum Eintrag von Antibiotika und multiresistenten Keimen in die Umwelt. Drucksache 17/10313, 17. Juli 2012, unter http://dip21.bundestag.de/dip21/btd/17/103/1710313. pdf(abgerufen im Oktober 2013).

Caporaso, J. G. et al.: Moving Pictures of the Human Microbiome. In: Genome Biol. 2011; 12 (5): S. R50.

Carvalho, B. M.; Saad, M. J.: Influence of Gut Microbiota on Subclinical Inflammation and Insulin Resistance. In: Mediators Inflamm. 2013; 2013: 986734.

Charalampopoulos, D.; Rastall, R. A.: Prebiotics in Foods. In: Current Opinion in Biotechnology. 2012, 23 (2): S. 187–191.

Chen, Y. et al.: Association Between Helicobacter Pylori and Mortality in the NHANES III Study. In: Gut. 2013 September; 62 (9): S. 1262–1269.

Devaraj, S. et al.: The Human Gut Microbiome and Body Metabolism: Implications for Obesity and Diabetes. In: Clin Chem. 2013 April; 59 (4): S. 617–628.

Dominguez-Bello, M. G. et al.: Development of the Human Gastrointestinal Microbiota and Insights from High-throughput Sequencing. In: Gastroenterology. 2011 May; 140 (6): S. 1713–1719.

Douglas, L. C.; Sanders, M. E.: Probiotics and Prebiotics in Dietetics Practice. In: J Am Diet Assoc. 2008 March; 108 (3): S. 510–521.

Eppinger, M. et al.: Who Ate Whom？ Adaptive Helicobacter Genomic Changes That Accompanied a Host Jump from Early Humans to Large Felines. In: PLoS Genet. 2006 July; 2 (7): S. e120.

Fahey, J. W. et al.: Urease from Helicobacter Pylori Is Inactivated by Sulforaphane and Other Isothiocyanates. In: Biochem Biophys Res Commun. 2013 May 24; 435 (1): S. 1–7.

Flegr, J.: Influence of Latent Toxoplasma Infection on Human Personality, Physiology and Morphology: Pros and Cons of the Toxoplasma–Human Model in Studying the Manipulation Hypothesis. In: J Exp Biol. 2013 January 1; 216 (Pt. 1): S. 127–133.

Flegr, J. et al.: Increased Incidence of Traffic Accidents in ToxoplasmaInfected Military Drivers and Protective Effect RhD Molecule Revealed by a LargeScale Prospective Cohort Study. In: BMC Infect Dis. 2009 May 26; 9: S. 72.

Flint, H. J.: Obesity and the Gut Microbiota. In. J Clin Gastroenterol. 2011 November; 45 (Suppl.): S. 128–132.

Fouhy, F. et al.: High-Throughput Sequencing Reveals the Incomplete, ShortTerm Recovery of Infant Gut Microbiota following Parenteral Antibiotic Treatment with Ampicillin and Gentamicin. In: Antimicrob Agents Chemother. 2012 November; 56 (11): S. 5811–5820.

Fuhrer, A. et al.: Milk Sialyllactose Influences Colitis in Mice Through Selective Intestinal Bacterial Colonization. In: J Exp Med. 2010 December 20; 207 (13): S. 2843–2854.

Gale, E. A. M.: A Missing Link in the Hygiene Hypothesis？. In: Diabetologia. 2002; 45 (4): S. 588–594.

Ganal, S. C. et al.: Priming of Natural Killer Cells by Non-mucosal Mononuclear Phagocytes Requires Instructive Signals from the Commensal Microbiota. In: Immunity. 2012 July 27; 37 (1): S: 171–186.

Gibney, M. J., Burstyn, P. G.: Milk, Serum Cholesterol, and the Maasai –A Hypothesis. In: Atherosclerosis. 1980; 35 (3): S. 339–343.

Gleeson, M. et al.: Daily Probiotic’s (Lactobacillus Sasei Shirota) Reduction of Infection Incidence in Athletes. In: Int J Sport Nutr Exerc Metab. 2011 February; 21 (1): S. 55–64.

Goldin, B. R.; Gorbach, S. L.: Clinical Indications for Probiotics: An Overview. In: Clinical Infectious Diseases. 2008; 46 (Suppl. 2): S. S96–S100.

Gorkiewicz, G.: Contribution of the Physiological Gut Microflora to Health and Disease. In: J Gastroenterol Hepatol Erkr. 2009; 7 (1): S. 15–18.

Grewe, K.: Prvalenz von Salmonella ssp. in der primren Geflügelproduktion und Broilerschlachtung – Salmonelleneintrag bei Schlachtgeflügel whrend des Schlachtprozesses. Hannover: Tierrztliche Hochschule Hannover, 2011.

Guseo, A.: The Parkinson Puzzle. In: Orv Hetil. 2012 December 30; 153 (52): S. 2060–2069.

Herbarth, O. et al.: Helicobacter Pylori Colonisation and Eczema. In: Journal of Epidemiology and Community Health. 2007; 61 (7): S. 638–640.

Hullar, M. A.; Lampe, J. W.: The Gut Microbiome and Obesity. In: Nestle Nutr Inst Workshop Ser. 2012; 73: S. 67–79.

Jernberg, C. et al.: Long-Term Impacts of Antibiotic Exposure on the Human Intestinal Microbiota. In: Microbiology. 2010 November; 156 (Pt. 11): S. 3216–3223.

Jin, C.; Flavell, R. A.: Innate Sensors of Pathogen and Stress: Linking Inflammation to Obesity. In: J Allergy Clin Immunol. 2013 August; 132 (2): S. 287–94.

Jirillo, E. et al.: Healthy Effects Exerted by Prebiotics, Probiotics, and Symbiotics with Special Reference to Their Impact on the Immune System. In: Int J Vitam Nutr Res. 2012 June; 82 (3): S. 200–208.

Jones, M. L. et al.: Cholesterol-Lowering Efficacy of a Microencapsulated Bile Salt Hydrolase-Active Lactobacillus Reuteri NCIMB 30242 Yoghurt Formulation in Hypercholesterolaemic Adults. In: British Journal of Nutrition. 2012; 107 (10): S. 1505–1513.

Jumpertz, R. et al.: Energy-Balance Studies Reveal Associations Between Gut Microbes, Caloric Load, and Nutrient Absorption in Humans. In: Am J Clin Nutr. 2011; 94 (1): S. 58–65.

Katz, S. E.: The Art of Fermentation: An In-Depth Exploration of Essential Concepts and Processes from Around the World. Chelsea: Chelsea Green Publishing, 2012.

Katz, S. E.: Wild Fermentation: The Flavor, Nutrition, and Craft of Live- Culture Foods Reclaiming Domesticity from a Consumer Culture. Chelsea: Chelsea Green Publishing, 2011.

Kountouras, J. et al.: Helicobacter Pylori Infection and Parkinson’s Disease: Apoptosis as an Underlying Common Contributor. In: Eur J Neurol. 2012 June; 19(6): S. e56.

Krznarica, Zeljko et al.: Gut Microbiota and Obesity. In: Dig Dis. 2012; 30: S. 196–200.

Kumar, M. et al.: Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases. In: Exp Diabetes Res. 2012; 2012: 902917.

Macfarlane, G. T. et al.: Bacterial Metabolism and Health-Related Effects of Galactooligosaccharides and Other Prebiotics. In: J Appl Microbiol. 2008 February; 104 (2): S. 305–344.

Mann, G. V. et al.: Atherosclerosis in the Masai. In: American Journal of Epidemiology. 1972; 95 (1): S. 26-37.

Marshall, B. J.: Unidentified Curved Bacillus on Gastric Epithelium in Active Chronic Gastritis. In: Lancet. 1983 June 4; 1 (8336): S. 1273 ff.

Martinson, V. G. et al.: A Simple and Distinctive Microbiota Associated with Honey Bees and Bumble Bees. In: Mol Ecol. 2011 February; 20 (3): S. 619–628.

Matamoros, S. et al.: Development of Intestinal Microbiota in Infants and its Impact on Health. In: Trends Microbiol. 2013 April; 21 (4): S. 167–173.

Moodley, Y. et al.: The Peopling of the Pacific from a Bacterial Perspective. In: Science. 2009 January 23; 323 (5913): S. 527–530.

Mori, K. et al.: Does the Gut Microbiota Trigger Hashimoto’s Thyroiditis？. In: Discov Med. 2012 November; 14 (78): S. 321–326.

Musso, G. et al.: Gut Microbiota as a Regulator of Energy Homeostasis and Ectopic Fat Deposition: Mechanisms and Implications for Metabolic Disorders. In: Current Opinion in Lipidology. 2010; 21 (1): S. 76–83.

Nagpal, R. et al.: Probiotics, their Health Benefits and Applications for Developing Healthier Foods: A Review. In: FEMS Microbiol Lett. 2012 September; 334 (1): S. 1–15.

Nakamura, Y. K.; Omaye, S. T.: Metabolic Diseases and Pro- and Prebiotics: Mechanistic Insights. In: Nutr Metab (Lond). 2012 June 19; 9 (1): S. 60.

Nicola, J. P. et al.: Functional Toll-like Receptor 4 Conferring Lipopolysaccharide Responsiveness is Expressed in Thyroid Cells. In: Endocrinology. 2009 January; 150 (1): S. 500–508.

Nielsen, H. H. et al.: Treatment for Helicobacter Pylori Infection and Risk of Parkinson’s Disease in Denmark. In: Eur J Neurol. 2012 June; 19 (6): S. 864–869.

Norris, V. et al.: Bacteria Control Host Appetites. In: J Bacteriol. 2013 February; 195 (3): S. 411–416.

Okusaga, O.; Postolache, T. T.: Toxoplasma Gondii, the Immune System, and Suicidal Behavior. In: Dwivedi, Y. (Hrsg.): The Neurobiological Basis of Suicide. Boca Raton, Florida: CRC Press, 2012:

S. 159–194.

Ottman, N. et al.: The Function of our Microbiota: Who Is Out There and What Do They Do？. In: Front Cell Infect Microbiol. 2012 August 9; 2: S. 104.

Pavlolvíc, N. et al.: Probiotics-Interactions with Bile Acids and Impact on Cholesterol Metabolism. In: Appl Biochem Biotechnol. 2012; 168: S. 1880–1895.

Petrof, E. O. et al.: Stool Substitute Transplant Therapy for the Eradication of Clostridium Difficile Infection: RePOOPulating the Gut. In: Microbiome. 2013 January 9; 1 (1): S. 3.

Reading, N. C.; Kasper, D. L.: The Starting Lineup: Key Microbial Players in Intestinal Immunity and Homeostasis. In: Front Microbiol. 2011 July 7; 2: S. 148.

Roberfroid, M. et al.: Prebiotic Effects: Metabolic and Health Benefits. In: Br J Nutr. 2010 August; 104 (Suppl. 2): S. S1–S63.

Sanders, M. E. et al.: An Update on the Use and Investigation of Probiotics in Health and Disease. In: Gut. 2013; 62 (5): S. 787–796.

Sanza, Y. et al.: Understanding the Role of Gut Microbes and Probiotics in Obesity: How Far Are We？. In: Pharmacol Res. 2013 March; 69 (1): S. 144–155.

Schmidt, C.: The Startup Bugs. In: Nat Biotechnol. 2013 April; 31 (4): S. 279–281.

Scholz-Ahrens, K. E. et al.: Prebiotics, Probiotics, and Synbiotics Affect Mineral Absorption, Bone Mineral Content, and Bone Structure. In: J Nutr. 2007 March; 137 (3 Suppl. 2): S. 838S–846S.

Schwarz, S. et al.: Horizontal versus Familial Transmission of Helicobacter Pylori. In: PLoS Pathog. 2008 October; 4 (10): S. e1000180.

Shen, J. et al.: The Gut Microbiota, Obesity and Insulin Resistance. In: Mol Aspects Med. 2013 February; 34 (1): S. 39–58.

Starkenmann, C. et al.: Olfactory Perception of Cysteine-S-Conjugates from Fruits and Vegetables. In: J Agric Food Chem. 2008 October 22; 56 (20): S. 9575–9580.

Stowell, S. R. et al.: Innate Immune Lectins Kill Bacteria Expressing Blood Group Antigen. In: Nat Med. 2010 March; 16 (3): S. 295–301.

Tngden, T. et al.: Foreign Travel Is a Major Risk Factor for Colonization with Escherichia Coli Producing CTX-M-Type Extended-Spectrum β-Lactamases: A Prospective Study with Swedish Volunteers. In: Antimicrob Agents Chemother. 2010 September; 54 (9): S. 3564–3568.

Teixeira, T. F. et al.: Potential Mechanisms for the Emerging Link Between Obesity and Increased Intestinal Permeability. In: Nutr Res. 2012 September; 32 (9): S. 637–647.

Torrey, E. F. et al.: Antibodies to Toxoplasma Gondii in Patients With Schizophrenia: A Meta-Analysis. In: Schizophr Bull. 2007 May; 33 (3): S. 729–736.

Tremaroli, V.; Bckhed, F.: Functional Interactions Between the Gut Microbiota and Host Metabolism. In: Nature. 2012 September 13; 489 (7415): S. 242–249.

Turnbaugh, P. J.; Gordon, J. I.: The Core Gut Microbiome, Energy Balance and Obesity. In: J Physiol. 2009; 587 (17): S. 4153–4158.

de Vrese, M.; Schrezenmeir, J.: Probiotics, Prebiotics, and Synbiotics. In: Adv Biochem Engin/Biotechnol. 2008; 111: S. 1–66.

de Vriese, J.: Medical Research. The Promise of Poop. In: Science. 2013 August 30; 341 (6149): S. 954–957.

Vyas, U.; Ranganathan, N.: Probiotics, Prebiotics, and Synbiotics: Gut and Beyond. In: Gastroenterol Res Pract. 2012; 2012: 872716.

Webster, J. P. et al.: Effect of Toxoplasma Gondii upon Neophobic Behaviour in Wild Brown Rats, Rattus norvegicus. In: Parasitology. 1994 July; 109 (Pt. 1): S. 37–43.

Wichmann-Schauer, H.: Verbrauchertipps: Schutz vor Lebensmittelinfektionen im Privathaushalt. Berlin: Bundesinstitut für Risikobewertung, 2007.

Wu, G. D. et al.: Linking Long-Term Dietary Patterns with Gut Microbial Enterotypes. In: Science. 2011 October 7; 334 (6052): S. 105–108.

Yatsunenko, T. et al.: Human Gut Microbiome Viewed Across Age and Geography. In: Nature. 2012 May 9; 486 (7402): S. 222–227.

Zipris, D.: The Interplay Between the Gut Microbiota and the Immune System in the Mechanism of Type 1 Diabetes. In: Curr Opin Endocrinol Diabetes Obes. 2013 August; 20 (4): S. 265–270.